Mangrove Partners »

Regeneron Pharmaceuticals shares owned by Mangrove Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Mangrove Partners from 13F filings

Historical chart of Mangrove Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Mangrove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Mangrove Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $769k 1.1k 712.33

More positions owned by Mangrove Partners

Ecd Automotive Design *w Exp 12/12/202 (ECDAW)
Indivior Ord (INDV)
Rio Tinto Sponsored Adr (RIO)
Atmus Filtration Technologies Ord (ATMU)
Enova Intl (ENVA)
Tempur-Pedic International (SGI)
Millrose Pptys Com Cl A (MRP)
Ecovyst (ECVT)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Open Text Corp (OTEX)
Flywire Corporation Com Vtg (FLYW)
PG&E Corporation (PCG)
Laureate Education Common Stock (LAUR)
News Corp Cl A (NWSA)
Bio Rad Labs Cl A (BIO)

View all positions for Mangrove Partners

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Jpmorgan Chase & Co
Geode Capital Management
Franklin Resources
Capital World Investors
Loomis, Sayles and
FMR
Invesco
Susquehanna International
Goldman Sachs Group
Nuveen
Northern Trust

View all funds holding Regeneron Pharmaceuticals